Discovery Labs (DSCO) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Discovery Labs Provides Business Update and Reports Second Quarter 2015 Financial Results
August 10, 2015 4:45 PM EDTWARRINGTON, Pa., Aug. 10, 2015 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today provided a corporate update, and announced financial results for the second quarter ended June 30, 2015. The Company will host a conference call Tuesday August 11, 2015 at 8:30 AM ET. Conference call details are below.
Key Highlights
In the second quarter of 2015, the Company implemented a plan to focus its resources on the development of its aerosolized KL4 surfactant for respiratory diseases, beginning with AEROSURF® for respiratory distress syndrome... More
